// App-Quantinova.ai

: A viral immunoevasin controls innate immunity by targeting the prototypical natural killer cell receptor family (NK1.1/NKR-P1)

Researchers

Presenter

  • James R Carlyle

Principal Investigators

  • Richard Berry

  • Mir Munir A Rahim

  • Johanna J Reichel

  • Branka Popovic

  • Miho Tanaka

  • Zhihui Fu

  • Gautham R Balaji

  • Timothy NH Lau

  • Megan M Tu

  • Christina L. Kirkham

  • Ahmad B Mahmoud

  • Aruz Mesci

  • Astrid Krmpotic

  • David S.J. Allanrew P Makrigiannis

  • Stipan Jonjic

  • Jamie Rossjohn

  • Oscar A Aguilar

Medical Centers

  • Univ. of Toronto, Canada

  • Sunnybrook Res. Inst., Canada

  • Monash Univ., Australia

  • Univ. of Ottawa, Canada

  • Dalhousie Univ., Canada

  • Univ. of Rijeka, Croatia

  • NHLBI, NIH

  • Cardiff Univ., United Kingdom

Locations

  • Canada

  • Australia

  • Croatia

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Cytomegalovirus infection

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved